Jakafi 10 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FDJG8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,365
Award facts
- Contract value 100% obligated
- $12,364.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform this work at its Park Ridge, Illinois facility.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. That underlying IDC, valued at $499.999 billion and awarded on November 13, 2025, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide. As a regional prime vendor contractor within the $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group serves as a critical supplier for Department of Defense healthcare operations, with the company's established performance on numerous prior delivery orders demonstrating its capacity to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FDJG8?
SPE2DR26FDJG8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FDJG8 worth?
The government has obligated $12,365 on SPE2DR26FDJG8.
Is contract SPE2DR26FDJG8 an order under another contract?
Yes. SPE2DR26FDJG8 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJG8 competed?
The extent of competition for SPE2DR26FDJG8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award